257 related articles for article (PubMed ID: 34335580)
21. Temporal patterns of cytokine and injury biomarkers in hospitalized COVID-19 patients treated with methylprednisolone.
Mwangi VI; Netto RLA; de Morais CEP; Silva AS; Silva BM; Lima AB; Neves JCF; Borba MGS; Val FFAE; de Almeida ACG; Costa AG; Sampaio VS; Gardinassi LG; de Lacerda MVG; Monteiro WM; de Melo GC
Front Immunol; 2023; 14():1229611. PubMed ID: 37662953
[TBL] [Abstract][Full Text] [Related]
22. Modulation of blood inflammatory markers by benralizumab in patients with eosinophilic airway diseases.
Sridhar S; Liu H; Pham TH; Damera G; Newbold P
Respir Res; 2019 Jan; 20(1):14. PubMed ID: 30658649
[TBL] [Abstract][Full Text] [Related]
23. Differentially expressed immune response genes in COVID-19 patients based on disease severity.
Li S; Duan X; Li Y; Li M; Gao Y; Li T; Li S; Tan L; Shao T; Jeyarajan AJ; Chen L; Han M; Lin W; Li X
Aging (Albany NY); 2021 Mar; 13(7):9265-9276. PubMed ID: 33780352
[TBL] [Abstract][Full Text] [Related]
24. CXCR3 and CCR5 chemokines in induced sputum from patients with COPD.
Costa C; Rufino R; Traves SL; Lapa E Silva JR; Barnes PJ; Donnelly LE
Chest; 2008 Jan; 133(1):26-33. PubMed ID: 17925429
[TBL] [Abstract][Full Text] [Related]
25. Increased LPS levels coexist with systemic inflammation and result in monocyte activation in severe COVID-19 patients.
Teixeira PC; Dorneles GP; Santana Filho PC; da Silva IM; Schipper LL; Postiga IAL; Neves CAM; Rodrigues Junior LC; Peres A; Souto JT; Fonseca SG; Eller S; Oliveira TF; Rotta LN; Thompson CE; Romão PRT
Int Immunopharmacol; 2021 Nov; 100():108125. PubMed ID: 34543980
[TBL] [Abstract][Full Text] [Related]
26. Proteomics validate circulating GDF-15 as an independent biomarker for COVID-19 severity.
Bu S; Royston L; Mabanga T; Berini CA; Tremblay C; Lebouché B; Cox J; Costiniuk CT; Durand M; Isnard S; Routy JP
Front Immunol; 2024; 15():1377126. PubMed ID: 38686386
[TBL] [Abstract][Full Text] [Related]
27. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.
Tacke F; Zimmermann HW; Berres ML; Trautwein C; Wasmuth HE
Liver Int; 2011 Jul; 31(6):840-9. PubMed ID: 21645215
[TBL] [Abstract][Full Text] [Related]
28. Comparison of serum biomarkers between patients with asthma and with chronic obstructive pulmonary disease.
Han SS; Lee WH; Hong Y; Kim WJ; Yang J; Lim MN; Lee SJ; Kwon JW
J Asthma; 2016 Aug; 53(6):583-8. PubMed ID: 27104648
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive Immunologic Evaluation of Bronchoalveolar Lavage Samples from Human Patients with Moderate and Severe Seasonal Influenza and Severe COVID-19.
Reynolds D; Vazquez Guillamet C; Day A; Borcherding N; Vazquez Guillamet R; Choreño-Parra JA; House SL; O'Halloran JA; Zúñiga J; Ellebedy AH; Byers DE; Mudd PA
J Immunol; 2021 Sep; 207(5):1229-1238. PubMed ID: 34348975
[TBL] [Abstract][Full Text] [Related]
30. Sinonasal pathology in nonallergic asthma and COPD: 'united airway disease' beyond the scope of allergy.
Hens G; Vanaudenaerde BM; Bullens DM; Piessens M; Decramer M; Dupont LJ; Ceuppens JL; Hellings PW
Allergy; 2008 Mar; 63(3):261-7. PubMed ID: 18053011
[TBL] [Abstract][Full Text] [Related]
31. The CXCL9/10/11-CXCR3 axis as a predictor of COVID-19 progression: a prospective, case-control study.
Çelik N; Çelik O; Laloğlu E; Özkaya A
Rev Soc Bras Med Trop; 2023; 56():e01282023. PubMed ID: 37493737
[TBL] [Abstract][Full Text] [Related]
32. The atopic dermatitis blood signature is characterized by increases in inflammatory and cardiovascular risk proteins.
Brunner PM; Suárez-Fariñas M; He H; Malik K; Wen HC; Gonzalez J; Chan TC; Estrada Y; Zheng X; Khattri S; Dattola A; Krueger JG; Guttman-Yassky E
Sci Rep; 2017 Aug; 7(1):8707. PubMed ID: 28821884
[TBL] [Abstract][Full Text] [Related]
33. Inflammatory mediators profile in patients hospitalized with COVID-19: A comparative study.
Tufa A; Gebremariam TH; Manyazewal T; Getinet T; Webb DL; Hellström PM; Genet S
Front Immunol; 2022; 13():964179. PubMed ID: 35958594
[TBL] [Abstract][Full Text] [Related]
34. Inverse association of plasma IL-13 and inflammatory chemokines with lung function impairment in stable COPD: a cross-sectional cohort study.
Lee JS; Rosengart MR; Kondragunta V; Zhang Y; McMurray J; Branch RA; Choi AM; Sciurba FC
Respir Res; 2007 Sep; 8(1):64. PubMed ID: 17868461
[TBL] [Abstract][Full Text] [Related]
35. Skin condition and its relationship to systemic inflammation in chronic obstructive pulmonary disease.
Majewski S; Pietrzak A; Tworek D; Szewczyk K; Kumor-Kisielewska A; Kurmanowska Z; Górski P; Zalewska-Janowska A; Piotrowski WJ
Int J Chron Obstruct Pulmon Dis; 2017; 12():2407-2415. PubMed ID: 28860735
[TBL] [Abstract][Full Text] [Related]
36. Elevated plasma levels of pigment epithelium-derived factor correlated with inflammation and lung function in COPD patients.
Li X; Wang T; Yang T; Shen Y; An J; Liu L; Dong J; Guo L; Li D; Zhang X; Chen L; Xu D; Wen F
Int J Chron Obstruct Pulmon Dis; 2015; 10():587-94. PubMed ID: 25844034
[TBL] [Abstract][Full Text] [Related]
37. Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients.
Contoli M; Papi A; Tomassetti L; Rizzo P; Vieceli Dalla Sega F; Fortini F; Torsani F; Morandi L; Ronzoni L; Zucchetti O; Pavasini R; Fogagnolo A; Volta CA; Bartlett NW; Johnston SL; Spadaro S; Campo G
Front Immunol; 2021; 12():648004. PubMed ID: 33767713
[No Abstract] [Full Text] [Related]
38. The clinical implication of serum cyclophilin A in patients with chronic obstructive pulmonary disease.
Zhang M; Tang J; Yin J; Wang X; Feng X; Yang X; Shan H; Zhang Q; Zhang J; Li Y
Int J Chron Obstruct Pulmon Dis; 2018; 13():357-363. PubMed ID: 29403273
[TBL] [Abstract][Full Text] [Related]
39. Differences in systemic inflammation between cigarette and biomass smoke-induced COPD.
Golpe R; Martín-Robles I; Sanjuán-López P; Pérez-de-Llano L; González-Juanatey C; López-Campos JL; Arellano-Orden E
Int J Chron Obstruct Pulmon Dis; 2017; 12():2639-2646. PubMed ID: 28979110
[TBL] [Abstract][Full Text] [Related]
40. Selection of disease-specific biomarkers by integrating inflammatory mediators with clinical informatics in AECOPD patients: a preliminary study.
Chen H; Song Z; Qian M; Bai C; Wang X
J Cell Mol Med; 2012 Jun; 16(6):1286-97. PubMed ID: 21883889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
